Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Advanced Medical Solutions ( (GB:AMS) ) has provided an announcement.
Advanced Medical Solutions Group plc reported strong growth in the first half of 2025, driven by momentum in its core surgical product portfolio and successful integration of recent acquisitions, Peters Surgical and Syntacoll. The restructuring of its Woundcare business has improved margins, contributing to the Group’s expected half-year revenue of approximately £110 million, up from £68 million in the previous year. The company remains confident in meeting full-year forecasts, with significant synergies anticipated from ongoing integrations.
The most recent analyst rating on (GB:AMS) stock is a Buy with a £2.45 price target. To see the full list of analyst forecasts on Advanced Medical Solutions stock, see the GB:AMS Stock Forecast page.
Spark’s Take on GB:AMS Stock
According to Spark, TipRanks’ AI Analyst, GB:AMS is a Neutral.
Advanced Medical Solutions shows strong growth potential with positive corporate events and solid financial structure. However, challenges in profitability and high valuation temper the overall outlook. Technical indicators offer a neutral perspective, suggesting the stock is currently fairly priced with potential for future gains if operational efficiencies improve.
To see Spark’s full report on GB:AMS stock, click here.
More about Advanced Medical Solutions
Advanced Medical Solutions Group plc (AMS) is a leading independent developer and manufacturer of innovative tissue-healing technologies, focusing on delivering quality outcomes for patients and value for payers. The company offers a wide range of surgical products, including tissue adhesives, sutures, haemostats, internal fixation devices, and internal sealants under various brands. AMS also provides wound care dressings through its ActivHeal® brand and has expanded its portfolio through several acquisitions since 2019. The company’s products are manufactured across multiple countries and sold globally through a network of partners and distributors, as well as direct sales forces.
Average Trading Volume: 637,511
Technical Sentiment Signal: Hold
Current Market Cap: £441.2M
Find detailed analytics on AMS stock on TipRanks’ Stock Analysis page.